trending Market Intelligence /marketintelligence/en/news-insights/trending/yWImQNIjCRSURPrBH1FOlQ2 content esgSubNav
In This List

Fennec Pharmaceuticals plans common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Fennec Pharmaceuticals plans common stock offering

Fennec Pharmaceuticals Inc. plans to offer its common shares in an underwritten public offering.

The biotechnology company also plans to grant the underwriters an option to buy up to an additional 15% of the common shares offered.

Wedbush PacGrow is acting as the sole book-running manager for the proposed offering, while H.C. Wainwright & Co. is acting as the co-manager.